
trainings
- SKAN/SMB/JYA Aseptic Behaviors for Isolators | Aug 19 - 21119 days to the eventAug 19, 2025, 8:00 AM EST – Aug 21, 2025, 12:15 PM ESTSKAN US HQ, Raleigh, NC, 7409 ACC Blvd, Raleigh, NC 27617, USA
- SKAN/SMB/JYA Aseptic Behaviors for Isolators | Nov 18 – 20210 days to the eventNov 18, 2025, 8:00 AM EST – Nov 20, 2025, 12:15 PM ESTSKAN US HQ, Raleigh, NC, 7409 ACC Blvd, Raleigh, NC 27617, USA

Aseptic Behaviors for Isolators Aug 19 – 21, 2025 Raleigh, NC
This 2.5 days course is an in-depth, hands-on training course on aseptic behaviors using isolators for sterile product manufacturing. This course will provide comprehensive knowledge of proper aseptic processing behaviors to ensure contamination control.
During this course, participants will learn about basics of microbiology, aseptic necessities during aseptic processing, basics of isolator technology, Vaporized Hydrogen Peroxide (VHP) decontamination and validation of isolators, FDA and EU (Annex 1) regulations for aseptic processing, environmental monitoring, isolator set-up and parts change over processing, proper aseptic movements in isolators, cleaning and disinfection of cleanrooms and isolators, gowning for aseptic processing in isolators, proper isolator glove use, isolator glove leak testing, sterile filtration of drug products/PUPSIT and risk assessments, aseptic processing simulations, intervention risk assessments, investigating APS failures, and air visualization studies in isolators.
At the end of the course, there will be an ask the experts session with the instructors as well as ex-FDA regulators from Jeff Yuen & Associates.

Aseptic Behaviors for Isolators Nov 18 – 20, 2025 Raleigh, NC
This 2.5 days course is an in-depth, hands-on training course on aseptic behaviors using isolators for sterile product manufacturing. This course will provide comprehensive knowledge of proper aseptic processing behaviors to ensure contamination control.
During this course, participants will learn about basics of microbiology, aseptic necessities during aseptic processing, basics of isolator technology, Vaporized Hydrogen Peroxide (VHP) decontamination and validation of isolators, FDA and EU (Annex 1) regulations for aseptic processing, environmental monitoring, isolator set-up and parts change over processing, proper aseptic movements in isolators, cleaning and disinfection of cleanrooms and isolators, gowning for aseptic processing in isolators, proper isolator glove use, isolator glove leak testing, sterile filtration of drug products/PUPSIT and risk assessments, aseptic processing simulations, intervention risk assessments, investigating APS failures, and air visualization studies in isolators.
At the end of the course, there will be an ask the experts session with the instructors as well as ex-FDA regulators from Jeff Yuen & Associates.

Dates: January, 2025
Location: Open Biopharma, Carlsbad, CA
This 1-day course is an in-depth, in-person, training course on how to establish an effective and comprehensive Contamination Control Strategy (CCS) for sterile product manufacturing as well as considerations for ATMPS, low-bioburden products and/or non-sterile products. This course will provide comprehensive knowledge of the elements that should be included in a CCS and will evaluate different document structures for a CCS.
During this course, participants will learn about Annex 1 requirements for CCS, elements of a CCS, relationships of contamination control risk assessments performed to the CCS (A CCS is NOT a risk assessment but should reference the risk assessments that have been performed), process and facility design, facilities and equipment, personnel, utilities, raw material controls, containers and closures, vendor approvals, management of outsourced activities, quality risk management, process validation, validation of sterilization processes, preventative maintenance, trends, CAPAs, continuous improvement and determine the best, most practical templates to document your CCS.
Working on your company CCS now and struggling? Bring your draft and get expert review and feedback on how to improve and finalize it.
WHO SHOULD ATTEND
Contamination Control Strategy Specialists, Managers
Microbiology leadership
Quality Assurance leadership
Internal/External auditors
MSAT
Upon completion of this course, participants will be able to:
Understand and interpret US and EU requirements for CCS
Describe the elements that should be included in the CCS
Develop and implement an effective CCS document
Understand how microbial risk assessments support the CCS
Describe how to measure the effectiveness of the CCS
Understand what CCS reference documents are available to aid in your CCS creation

Dates: January, 2025
Location: Open Biopharma, Carlsbad, CA
This 1-day course is an in-depth, in-person, training course on how to establish an effective and comprehensive Environmental Monitoring (EM) for sterile product manufacturing as well as for ATMPS, low-bioburden products and/or non-sterile products and compounding pharmacies. This course will provide comprehensive knowledge of the basics of EM, the regulatory and compendial requirements for EM, how to perform a risk assessment for your EM Program and requirements for EM Performance Qualification (EMPQ).
During this course, participants will learn about FDA and EU Annex 1 requirements for EM, USP 1115 & 1116, basics of environmental monitoring (traditional and modern EM equipment, types of media, incubation schemes, analyst training, etc.), how to perform and EMRA, differences between cleanroom classification, EMPQ and routine EM. Let’s get back to basics in this interactive course and discuss everything you need to know to have an effective environmental monitoring program.
WHO SHOULD ATTEND
Environmental Monitoring analysts/supervisors/managers
Contamination Control Strategy Specialists, Managers
Microbiology leadership
Quality Assurance leadership
Internal/External auditors
Upon completion of this course, participants will be able to:
Understand and interpret US and EU requirements for EM
Describe the elements that should be included in the EM Program
Develop and implement an effective EMPQ
Develop and document an EM risk assessments
Describe how to measure the effectiveness of the EM Program
Understand what EM regulatory and reference documents are available to aid in your EM Program
